WCN24-1153 THE EFFICACY AND SAFETY OF NOVEL ANTICOAGULANTS FOR PREVENTING THROMBOEMBOLIC EVENTS IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION. A SYSTEMATIC REVIEW AND METAANALYSIS

WCN24-1153 THE EFFICACY AND SAFETY OF NOVEL ANTICOAGULANTS FOR PREVENTING THROMBOEMBOLIC EVENTS IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION. A SYSTEMATIC REVIEW AND METAANALYSIS

Saved in:

Bibliographic Details
Main Authors:	Digbijay kunwar, Fnu Muhibullah, Muhammad Talha, Shahroze Ahmed, Faiza Ashfaque, Achit Singh
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924007460
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

NOVEL ANTICOAGULANTS FOR THROMBOEMBOLIC COMPLICATIONS PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
by: D. A. Itkin, et al.
Published: (2015-02-01)

Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF)
by: Raffaele De Caterina, et al.
Published: (2019-03-01)

ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
by: A. V. Rudakova
Published: (2015-09-01)

THE ENDOVASCULAR PREVENTION OF THROMBOEMBOLISM IN ATRIAL FIBRILLATION
by: Rami N. Al-Ayyubi, et al.
Published: (2018-12-01)

Effect of drug interactions with non-vitamin-K oral anticoagulants on thromboembolic events in patients with nonvalvular atrial fibrillation
by: Jin-Hua Chen, et al.
Published: (2024-02-01)

WCN24-2108 IS TOLVAPTAN A PROTECTIVE AGENT FOR CARDIAC INSUFFICIENCY IN PERITONEAL DIALYSIS PATIENTS?A METAANALYSIS
by: Stylianou Konstantinos, et al.
Published: (2024-04-01)

Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true
by: Yu. A. Bunin, et al.
Published: (2016-09-01)

Anticoagulation in Atrial Fibrillation With Valvular Heart Disease
by: Ana Catarina Fonseca, et al.
Published: (2025-02-01)

Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2020-05-01)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-11-01)

Atrial Fibrillation Ablation without Interruption of Anticoagulation
by: Pasquale Santangeli, et al.
Published: (2011-01-01)

Patients with atrial fibrillation and a low risk of thromboembolic events: prescription rate of anticoagulant therapy according to a retrospective analysis
by: M. A. Druzhilov, et al.
Published: (2023-09-01)

Impact of preprocedural anticoagulation on the incidence of silent cerebral embolisms after catheter ablation of atrial fibrillation in patients with low thromboembolic risk
by: Meng Wang, et al.
Published: (2025-04-01)

RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION
by: M. Yu. Gilyarov
Published: (2015-12-01)

PREDICTION OF THROMBOEMBOLISM IN PATIENTS WITH LONG-LASTING ATRIAL FIBRILLATION
by: R. D. Kurbanov, et al.
Published: (2014-03-01)

Relationship between the type of atrial fibrillation and thromboembolic events
by: Potpara Tatjana, et al.
Published: (2009-01-01)

Short-Term Anticoagulation After Cardioversion in New-Onset Atrial Fibrillation and Low Thromboembolic Risk: A Real-World International Investigation
by: Alan Poggio, et al.
Published: (2025-06-01)

Anticoagulant therapy in catheter ablation of atrial fibrillation and flutter
by: M. V. Serova, et al.
Published: (2021-09-01)

CURRENT POSSIBILITIES OF ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION
by: M. Yu. Gilyarov, et al.
Published: (2015-10-01)

Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage
by: A. S. Gerasimenko, et al.
Published: (2021-05-01)

Challenges of anticoagulant treatment in atrial fibrillation with liver disease
by: Alina Doina Nicoara, et al.
Published: (2024-10-01)

Mild Renal Dysfunction and Risk of Thromboembolism and Bleeding in Patients with Atrial Fibrillation: The Chinese Atrial Fibrillation Registry Study
by: Jingye Li, et al.
Published: (2021-03-01)

Left Atrial Appendage Closure in Atrial Fibrillation: A World without Anticoagulation?
by: Tahmeed Contractor, et al.
Published: (2011-01-01)

Bleeding and Thrombotic Events in Hemodialysis Patients with Atrial Fibrillation on Anticoagulation and Antiplatelet Therapy: A 24-Month Cohort Study
by: Zorica M. Dimitrijevic, et al.
Published: (2024-10-01)

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
by: Paula Tiili, et al.
Published: (2021-01-01)

Specifics of anticoagulation in combination with atrial fibrillation and chronic kidney disease
by: N. Sh. Zagidullin, et al.
Published: (2021-10-01)

Contribution of anticoagulant therapy adherence to the risk of complications of atrial fibrillation
by: Yu. P. Skirdenko, et al.
Published: (2019-03-01)

New safety standards for anticoagulant therapy in the treatment of atrial fibrillation
by: E. I. Baranova
Published: (2018-11-01)

Hypertension, chronic kidney disease, atrial fibrillation and the newer anticoagulants
by: B. Rayner
Published: (2012-10-01)

Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction
by: Z. D. Kobalava, et al.
Published: (2021-03-01)

THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY
by: M. Yu. Gilyarov
Published: (2015-12-01)

Factors determining adherence to anticoagulant therapy in patients with atrial fibrillation
by: D. V. Pevzner, et al.
Published: (2023-06-01)

Systemic anticoagulation in progressive chronic kidney disease and atrial fibrillation
by: Henning Hansen-Nootbaar, et al.
Published: (2025-04-01)

GENETIC POLYMORPHISM OF INFLAMMATORY FACTORS IS ASSOCIATED WITH THROMBOEMBOLIC COMPLICATIONS OF ATRIAL FIBRILLATION
by: I. V. Zotova, et al.
Published: (2015-10-01)

Joint effects of atrial fibrillation and prothrombotic genotypes on the risk of venous thromboembolism
by: Erin Mathiesen Hald, et al.
Published: (2025-05-01)

PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION
by: A. V. Rudakova
Published: (2015-09-01)

Preventing bleeding and thromboembolic complications in atrial fibrillation patients undergoing surgery
by: Charles André
Published: (2015-08-01)

WCN25-1153 BASELINE DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS WITH ESKD UNDERGOING HEMODIALYSIS AT A PRIVATE TERTIARY HOSPITAL IN NAIROBI, KENYA
by: Hussein Bagha, et al.
Published: (2025-02-01)

Anticoagulation and atrial fibrillation in prognostic models for type B aortic dissection
by: Amir Reza Akbari, et al.
Published: (2025-07-01)

New aspects of anticoagulant therapy in atrial fibrillation in patients with renal dysfunction
by: Zh. D. Kobalava, et al.
Published: (2020-12-01)